BIO vs WAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 19, 2026
BIO
WAT
Investment Advisor Scores
WAT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BIO | WAT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 41.3223 | 24.7525 | WAT |
| PEG Ratio | 1.1905 | 1.5658 | BIO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -0.1% | 113.4% | WAT |
| Earnings Growth | 18.7% | -3.1% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.7/100 | 48.1/100 | BIO |
| Profit Margin | 8.6% | 3.6% | BIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BIO
NeutralMixed signals - no dominant trend phase, RSI 39
WAT
MarkupPrice above SMA50, rising 50-day trend (5.4% over 20 days), RSI 54
Fundamentals Snapshot
| Metric | BIO | WAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 36.2 | 26.3 |
| Trailing P/E | 44.8 | 110.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 1.1% |
| Gross Margin | 0.5% | 0.6% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 7.89 | 3.95 |
| Dividend Yield | — | — |